U-Neuron Biomedical Inc (TPEX:6973)
Taiwan · Delayed Price · Currency is TWD 36.00
-0.40 (-1.10%)
Aug 4, 2026, 12:34 PM CST
U-Neuron Biomedical Market Cap
U-Neuron Biomedical has a market cap or net worth of 1.08 billion as of August 4, 2026. Its market cap has increased by 2.10% in one year.
Market Cap
1.08B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
36.00
ChartMarket Cap Chart
Since July 20, 2023, U-Neuron Biomedical's market cap has decreased from 1.36B to 1.08B, a decrease of -20.87%. That is a compound annual growth rate of -7.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.08B | -3.96% |
| Dec 31, 2025 | 1.12B | -9.44% |
| Dec 31, 2024 | 1.24B | -30.25% |
| Dec 29, 2023 | 1.77B | 30.43% |
| Jul 20, 2023 | 1.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.35B |
| Abnova (Taiwan) | 1.27B |
| Enimmune | 1.13B |
| BiOptic | 1.12B |
| LabTurbo Biotech | 1.10B |
| Bio Preventive Medicine | 1.07B |
| Level Biotechnology | 1.03B |
| GeneReach Biotechnology | 994.21M |